Skip to main navigation Skip to search Skip to main content

Organogels: "GelVolution" in Topical Drug Delivery - Present and Beyond

  • Ajinkya Nitin Nikam
  • , Amrita Roy
  • , Ruchira Raychaudhuri
  • , Prerana D. Navti
  • , Soji Soman
  • , Sanjay Kulkarni
  • , Krishnaraj Somayaji Shirur
  • , Abhijeet Pandey
  • , Srinivas Mutalik*
  • *Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

Topical drug delivery holds immense significance in dermatological treatments due to its non-invasive nature and direct application to the target site. Organogels, a promising class of topical drug delivery systems, have acquired substantial attention for enhancing drug delivery efficiency. This review article aims to explore the advantages of organogels, including enhanced drug solubility, controlled release, improved skin penetration, non-greasy formulations, and ease of application. The mechanism of organogel permeation into the skin is discussed, along with formulation strategies, which encompass the selection of gelling agents, cogelling agents, and additives while considering the influence of temperature and pH on gel formation. Various types of organogelators and organogels and their properties, such as viscoelasticity, non-birefringence, thermal stability, and optical clarity, are presented. Moreover, the biomedical applications of organogels in targeting skin cancer, anti-inflammatory drug delivery, and antifungal drug delivery are discussed. Characterization parameters, biocompatibility, safety considerations, and future directions in optimizing skin permeation, ensuring long-term stability, addressing regulatory challenges, and exploring potential combination therapies are thoroughly examined. Overall, this review highlights the immense potential of organogels in redefining topical drug delivery and their significant impact on the field of dermatological treatments, thus paving the way for exciting prospects in the domain.

Original languageEnglish
Pages (from-to)489-518
Number of pages30
JournalCurrent Pharmaceutical Design
Volume30
Issue number7
DOIs
Publication statusPublished - 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Drug Discovery

Fingerprint

Dive into the research topics of 'Organogels: "GelVolution" in Topical Drug Delivery - Present and Beyond'. Together they form a unique fingerprint.

Cite this